These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 29171670

  • 1. Potential treatment for vocal fold scar with pirfenidone.
    Kodama H, Kumai Y, Nishimoto K, Toya Y, Miyamaru S, Furushima S, Yumoto E.
    Laryngoscope; 2018 May; 128(5):E171-E177. PubMed ID: 29171670
    [Abstract] [Full Text] [Related]

  • 2. Effect of pirfenidone injection on ferret vocal fold scars: A preliminary in vivo study.
    Yamada T, Kumai Y, Kodama H, Nishimoto K, Miyamaru S, Onoue S, Orita Y.
    Laryngoscope; 2020 Mar; 130(3):726-731. PubMed ID: 31180582
    [Abstract] [Full Text] [Related]

  • 3. Cryotherapy has antifibrotic and regenerative effects on human vocal fold fibroblasts.
    Gong T, Zhang C, Kang J, Lamb JJ, Jiang JJ.
    Laryngoscope; 2019 Apr; 129(4):E143-E150. PubMed ID: 30315572
    [Abstract] [Full Text] [Related]

  • 4. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
    Zhou C, Liu F, Gallo PH, Baratz ME, Kathju S, Satish L.
    BMC Musculoskelet Disord; 2016 Nov 11; 17(1):469. PubMed ID: 27835939
    [Abstract] [Full Text] [Related]

  • 5. Crosstalk between adipose-derived stem/stromal cells and vocal fold fibroblasts in vitro.
    Kumai Y, Kobler JB, Park H, Lopez-Guerra G, Karajanagi S, Herrera VL, Zeitels SM.
    Laryngoscope; 2009 Apr 11; 119(4):799-805. PubMed ID: 19263411
    [Abstract] [Full Text] [Related]

  • 6. Mesenchymal stem cells have antifibrotic effects on transforming growth factor-β1-stimulated vocal fold fibroblasts.
    Hiwatashi N, Bing R, Kraja I, Branski RC.
    Laryngoscope; 2017 Jan 11; 127(1):E35-E41. PubMed ID: 27345475
    [Abstract] [Full Text] [Related]

  • 7. Pirfenidone suppresses TGF‑β1‑induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K/AKT signaling pathway.
    Sun Y, Zhang Y, Chi P.
    Mol Med Rep; 2018 Oct 11; 18(4):3907-3913. PubMed ID: 30152848
    [Abstract] [Full Text] [Related]

  • 8. Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for idiopathic pulmonary fibrosis.
    Togami K, Kanehira Y, Tada H.
    Biol Pharm Bull; 2013 Oct 11; 36(10):1525-7. PubMed ID: 24088250
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pirfenidone suppresses keloid fibroblast-embedded collagen gel contraction.
    Saito M, Yamazaki M, Maeda T, Matsumura H, Setoguchi Y, Tsuboi R.
    Arch Dermatol Res; 2012 Apr 11; 304(3):217-22. PubMed ID: 22033529
    [Abstract] [Full Text] [Related]

  • 11. Stem Cell-Mediated Paracrine Signaling Alters Fibroplasia in Human Vocal Fold Fibroblasts in Vitro.
    Hiwatashi N, Bing R, Kraja I, Branski RC.
    Ann Otol Rhinol Laryngol; 2017 Aug 11; 126(8):581-588. PubMed ID: 28635301
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Photodynamic therapy induces antifibrotic alterations in primary human vocal fold fibroblasts.
    Zhang C, Wang J, Chou A, Gong T, Devine EE, Jiang JJ.
    Laryngoscope; 2018 Sep 11; 128(9):E323-E331. PubMed ID: 29668038
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of cytosporone-B, a novel antifibrotic agent, on vocal fold fibroblasts.
    Hiwatashi N, Mukudai S, Bing R, Branski RC.
    Laryngoscope; 2018 Dec 11; 128(12):E425-E428. PubMed ID: 30325029
    [Abstract] [Full Text] [Related]

  • 18. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
    Jin J, Togo S, Kadoya K, Tulafu M, Namba Y, Iwai M, Watanabe J, Nagahama K, Okabe T, Hidayat M, Kodama Y, Kitamura H, Ogura T, Kitamura N, Ikeo K, Sasaki S, Tominaga S, Takahashi K.
    Respir Res; 2019 Jun 11; 20(1):119. PubMed ID: 31185973
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
    Zhao XY, Zeng X, Li XM, Wang TL, Wang BE.
    Clin Exp Pharmacol Physiol; 2009 Oct 11; 36(10):963-8. PubMed ID: 19413596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.